Steve Horwitz

1.4k total citations
7 papers, 90 citations indexed

About

Steve Horwitz is a scholar working on Pathology and Forensic Medicine, Dermatology and Molecular Biology. According to data from OpenAlex, Steve Horwitz has authored 7 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Dermatology and 2 papers in Molecular Biology. Recurrent topics in Steve Horwitz's work include Lymphoma Diagnosis and Treatment (5 papers), Cutaneous lymphoproliferative disorders research (4 papers) and T-cell and Retrovirus Studies (2 papers). Steve Horwitz is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Cutaneous lymphoproliferative disorders research (4 papers) and T-cell and Retrovirus Studies (2 papers). Steve Horwitz collaborates with scholars based in United States, Australia and Italy. Steve Horwitz's co-authors include Boyu Hu, Meredith Little, Keenan Fenton, Jasmine Zain, Matthew Onsum, William L. Trepicchio, Anca Prica, Madeleine Duvic, R. Alejandro Sica and P. Joy Ho and has published in prestigious journals such as Blood, Annals of Oncology and Journal of Investigative Dermatology.

In The Last Decade

Steve Horwitz

7 papers receiving 89 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Horwitz United States 4 42 41 35 31 18 7 90
Robert Stuver United States 6 44 1.0× 71 1.7× 45 1.3× 47 1.5× 11 0.6× 28 99
Nur-Taz Rahman United States 5 40 1.0× 17 0.4× 42 1.2× 36 1.2× 54 3.0× 8 135
Mark Wong United States 6 78 1.9× 28 0.7× 37 1.1× 154 5.0× 30 1.7× 15 188
Xavier Roussel France 6 41 1.0× 10 0.2× 8 0.2× 18 0.6× 24 1.3× 13 84
Sarah Noor United States 6 32 0.8× 42 1.0× 75 2.1× 31 1.0× 9 0.5× 25 119
Melek Koç Türkiye 7 15 0.4× 36 0.9× 52 1.5× 70 2.3× 32 1.8× 12 142
Philip Pancari United States 3 8 0.2× 33 0.8× 16 0.5× 17 0.5× 23 1.3× 6 76
Sascha Kretschmann Germany 5 79 1.9× 7 0.2× 9 0.3× 56 1.8× 25 1.4× 8 109
Justin Golovato United States 4 33 0.8× 14 0.3× 40 1.1× 12 0.4× 34 1.9× 5 104
Natasja Nielsen Viller United States 5 70 1.7× 24 0.6× 30 0.9× 151 4.9× 43 2.4× 11 187

Countries citing papers authored by Steve Horwitz

Since Specialization
Citations

This map shows the geographic impact of Steve Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Horwitz more than expected).

Fields of papers citing papers by Steve Horwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Horwitz. The network helps show where Steve Horwitz may publish in the future.

Co-authorship network of co-authors of Steve Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Horwitz. A scholar is included among the top collaborators of Steve Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Horwitz. Steve Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Jagadeesh, Deepa, Steve Horwitz, Nancy L. Bartlett, et al.. (2022). Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma. The Oncologist. 27(10). 864–873. 28 indexed citations
3.
Kurzrock, Razelle, Lisa A. Gurski, Robert W. Carlson, et al.. (2019). Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals. Annals of Oncology. 30(10). 1647–1652. 9 indexed citations
4.
Geller, Shamir, et al.. (2019). Outcomes and prognostic factors in African American/black patients with mycosis fungoides and Sézary syndrome. European Journal of Cancer. 119. S9–S9. 2 indexed citations
5.
Whittaker, Sean, Steve Horwitz, Madeleine Duvic, et al.. (2017). 262 Brentuximab vedotin demonstrates superior activity to standard therapy in CD30-expressing (CD30+) cutaneous T-cell lymphoma (CTCL) in the randomized phase 3 ALCANZA study. Journal of Investigative Dermatology. 137(5). S45–S45. 1 indexed citations
6.
Haverkos, Bradley M., Rebecca Kohnken, Alejandro A. Gru, et al.. (2016). Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?. Expert Review of Hematology. 10(2). 111–121. 11 indexed citations
7.
Kewalramani, Tarun, Steve Horwitz, Andrew D. Zelenetz, Stephen D. Nimer, & Craig H. Moskowitz. (2007). Late Relapses Characterize Autologous Transplantation (ASCT) in First Complete Remission (CR) for Peripheral T-Cell Lymphoma (PTCL).. Blood. 110(11). 5110–5110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026